fundingUncategorizedUSAventure capital

Vormetric, a San Jose, Calif.-based provider of data-centric security solutions, raised $15m in funding. The round was led by Split Rock Partners, with participation from existing investors JK&B Capital, Quicksilver Ventures and Sigma Partners. In conjunction with the funding, Jim Simons, managing director at Split Rock Partners, is joining Vormetric’s board of directors. The company […]

fundingStart UpUncategorizedUSAventure capital

Ludei, a San Francisco, CA-based platform for mobile developers to create, accelerate and publish HTML5-based apps and games, raised $1.5m in funding. Bckers included Spanish venture capitalists Kibo Ventures and Vitamina K, as well as other angel investors. The company intends to use the funds to expand its JavaScript/HTML5 engineering team. Led by CEO Eneko Knorr, Ludei […]

fundingStart UpUSAventure capital

NuMedii, Inc., a Menlo Park, CA-based drug discovery company, received $3.5m in Series A funding. The round was led by Claremont Creek Ventures and Lightspeed Venture Partners, with participation from Life Science Angels and others. In conjunction with the funding, Ted Driscoll, Ph.D., Venture Partner at Claremont Creek Ventures, will serve as Chairman of the board. Brad […]

fundingStart UpUncategorizedUSAventure capital

Socrata, a Seattle, WA-based cloud software company that focuses on democratizing access to data in government, closed an $18m Series B financing. The round was led by OpenView Venture Partners, with participation from existing investors Morgenthaler Ventures and Frazier Technology Partners. In conjunction with the funding, Scott Maxwell, OpenView’s senior managing director and founder, will […]

NetherlandsStart Up

Kiadis Pharma B.V., an Amsterdam, The Netherlands-based clinical stage biopharmaceutical company developing treatments for blood cancers, is to receive an innovation credit of up to €3m from AgentschapNL, a division of the Dutch Ministry of Economic Affairs. The line will support the Phase II clinical development of Kiadis Pharma’s lead pipeline product, ATIR™. The company […]

BelgiumfundingStart Upventure capital

Complix, a Hasselt (Belgium)-based biopharmaceutical company focused on the discovery and development of a class of protein therapeutics active against intracellular disease targets, closed a €12m (approximately US$15.5m) Series B equity financing. The round was co-led by new investors Edmond de Rothschild Investment Partners (France) and Gimv (Belgium) and Biotech Fund Flanders (managed by Gimv), […]

fundingStart UpUSAventure capital

The Bouqs Company, a Venice Beach, California-based online flower delivery company, raised $1.1m in seed funding. Backers included Quest Venture Partners and Siemer Ventures, as well as angel investors Mich Mathews, former CMO of Microsoft, Dennis Phelps, partner at Institutional Venture Partners, Andy Dunn, CEO/founder of Bonobos, and Brian Spaly, CEO/founder of Trunk Club. The […]

fundingStart UpUSAventure capital

Mevion Medical Systems, Inc., a Boston, MA-based provider of single-room proton therapy systems for the treatment of cancer, secured $55m in funding. Backers included existing investors Caxton Heath Life Sciences, ProQuest Investments, Venrock, and CHL Medical Partners. Life Sciences Alternative Funding LLC provided debt financing. The company intends to use the capital to grow business […]

Sweden

Artificial Solutions, a developer of a natural language interaction (NLI) platform designed to enable users to have a humanlike interaction with technology, raised $9.4m (approximately €7.3m), in its third round of funding. The round was led by Scope. The company intends to use the funds to expand into the US and further develop its solutions. […]

fundingGermanyStart Upventure capital

According to the corporate blog (read here) Contentful, a Berlin-Germany-based provider of a cloud-based content management platform for web and mobile apps, recently raised a seed funding round of undisclosed amount. The round was led by Balderton Capital (Roberto Bonanzinga), with participation from Point Nine Capital (Christoph Janz) and angels. The company intends to use […]